Beyond Air, Inc. Amortization of Debt Issuance Costs
Beyond Air, Inc. (XAIR) reported Amortization of Debt Issuance Costs of $71.00 thousand for the 9-month period ending 2021-12-31, per its 10-Q filed 2022-02-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2022-02-10
- Beyond Air, Inc. amortization of debt issuance costs for the quarter ending 2021-12-31 was $49.00K.
- Beyond Air, Inc. amortization of debt issuance costs for the quarter ending 2021-09-30 was $7.25K.
- Beyond Air, Inc. amortization of debt issuance costs for the quarter ending 2021-06-30 was $14.75K.
- Beyond Air, Inc. amortization of debt issuance costs for the quarter ending 2017-12-31 was -$727.00, a 118.18% decline year-over-year.
- Beyond Air, Inc. amortization of debt issuance costs for fiscal 2020 was $545.00.
- Beyond Air, Inc. amortization of debt issuance costs for fiscal 2017 was $14.27K, a 10.79% decline from fiscal 2016.
- Beyond Air, Inc. amortization of debt issuance costs for fiscal 2016 was $16.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 3 month as first filed | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-12-31 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-10 | $56.25K derived: sum of 2 quarters · filed 2022-02-10 | $71.00K 10-Q · filed 2022-02-10 | |||
| 2021-09-30 | $7.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-12 | $22.00K 10-Q · filed 2021-11-12 | ||||
| 2021-06-30 | $14.75K 10-Q · filed 2021-08-10 | |||||
| 2021-03-31 | $15.00K 10-Q · filed 2022-02-10 | $14.75K 10-K · filed 2021-06-10 | ||||
| 2020-03-31 | $545.00 10-K · filed 2021-06-10 | |||||
| 2017-12-31 | -$727.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-28 | -$727.00 derived: sum of 2 quarters · filed 2019-06-28 | $0.00 derived: sum of 3 quarters · filed 2019-06-28 | $14.27K 10-K · filed 2019-06-28 | $14.00K 10-K · filed 2018-03-30 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $727.00 derived: sum of 2 quarters · filed 2017-11-03 | $15.00K 10-Q · filed 2017-11-03 | $19.00K derived: sum of 4 quarters · filed 2019-06-28 | ||
| 2017-06-30 | $727.00 derived: 10-Q 6 month − 10-K 3 month · filed 2017-08-11 | $15.00K 10-Q · filed 2017-08-11 | $19.00K derived: sum of 3 quarters · filed 2019-06-28 | $23.00K derived: sum of 4 quarters · filed 2019-06-28 | ||
| 2017-03-31 | $14.27K 10-K · filed 2019-06-28 | $15.00K 10-Q · filed 2017-05-15 | $18.27K derived: sum of 2 quarters · filed 2019-06-28 | $22.27K derived: sum of 3 quarters · filed 2019-06-28 | $26.27K derived: sum of 4 quarters · filed 2019-06-28 | |
| 2016-12-31 | $4.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2018-06-15 | $8.00K derived: sum of 2 quarters · filed 2018-06-15 | $12.00K derived: sum of 3 quarters · filed 2018-06-15 | $16.00K 10-KT · filed 2018-06-15 | ||
| 2016-09-30 | $4.00K 10-Q · filed 2017-11-03 | $8.00K derived: sum of 2 quarters · filed 2017-11-03 | $12.00K 10-Q · filed 2017-11-03 | |||
| 2016-06-30 | $4.00K 10-Q · filed 2017-08-11 | $8.00K 10-Q · filed 2017-08-11 | ||||
| 2016-03-31 | $4.00K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |